[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fJEtdYzh7FcfrYnRplPuI0h2kyWfPC8JWanENL84gRgE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Hamad Medical Corporation",[4],133,false,17,18,222109,3,76,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"COVID-19",6,{"name":18,"count":19},"Bronchiolitis",5,{"name":21,"count":22},"Diabetes Mellitus",4,{"name":24,"count":22},"Covid19",{"name":26,"count":22},"Extracorporeal Membrane Oxygenation Complication",{"name":28,"count":11},"Gastroenteritis",{"name":30,"count":11},"COVID-19 Pneumonia",{"name":32,"count":11},"Asthma",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT03523221","Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis","2024-12","Dexamethasone",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06618365","Oral or Intra Muscular Vitamin D2 Vs Oral or Intra Muscular Vitamin D3 in Treatment of Vitamin D Deficiency","2025-07","Vitamin D Deficiency",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06548477","Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages","2027-07-31","Human albumin",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,107,128,150,175,205,223,241,259,286,311,340,367,385,411,437,455,483,509,527,555,573,591,615,633,660,687,705,723,750,776,801,827,855,873,901,929,957,983,1001,1027,1045,1071,1089,1116,1134,1152,1170,1195,1219,1243,1268,1294,1312,1340,1358,1384,1409,1438,1463,1485,1510,1535,1568,1604,1632,1650,1677,1695,1722,1740,1758,1783,1801,1825,1850,1878,1905,1923,1941],{"intervention":38,"totalTrials":11,"cells":58},{"EARLY_PHASE1":59,"PHASE1":62,"PHASE2":83,"PHASE3":85,"PHASE4":103,"NA":105},{"trials":60,"activeCount":61},[],0,{"trials":63,"activeCount":82,"soonestReadout":37},[64,74],{"nctId":65,"briefTitle":66,"status":67,"phases":68,"primaryCompletion":69,"completion":69,"start":70,"enrollment":71,"conditions":72,"interventions":73},"NCT01065272","Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma","COMPLETED",[51],"2012-08","2010-02",200,[18],[38],{"nctId":35,"briefTitle":36,"status":75,"phases":76,"primaryCompletion":37,"completion":37,"start":77,"enrollment":78,"conditions":79,"interventions":81},"RECRUITING",[51],"2018-04-15",210,[80],"Anaphylaxis",[38],1,{"trials":84,"activeCount":61},[],{"trials":86,"activeCount":61},[87],{"nctId":88,"briefTitle":89,"status":90,"phases":91,"primaryCompletion":92,"completion":37,"start":93,"enrollment":94,"conditions":95,"interventions":102},"NCT04654507","Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children","UNKNOWN",[53],"2023-12","2021-03-03",120,[96,38,97,98,99,100,101],"Urinary Tract Infections in Children","Kidney Scarring","Acute Pyelonephritis","Hypertension in Children","Chronic Renal Failure","UTI",[38],{"trials":104,"activeCount":61},[],{"trials":106,"activeCount":61},[],{"intervention":48,"totalTrials":82,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":113,"PHASE3":115,"PHASE4":117,"NA":119},{"trials":110,"activeCount":61},[],{"trials":112,"activeCount":61},[],{"trials":114,"activeCount":61},[],{"trials":116,"activeCount":61},[],{"trials":118,"activeCount":61},[],{"trials":120,"activeCount":82,"soonestReadout":47},[121],{"nctId":45,"briefTitle":46,"status":75,"phases":122,"primaryCompletion":47,"completion":47,"start":123,"enrollment":124,"conditions":125,"interventions":127},[55],"2024-08-01",84,[126],"Aneurysmal Subarachnoid Hemorrhage",[48],{"intervention":43,"totalTrials":82,"cells":129},{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":140},{"trials":131,"activeCount":61},[],{"trials":133,"activeCount":61},[],{"trials":135,"activeCount":61},[],{"trials":137,"activeCount":61},[],{"trials":139,"activeCount":61},[],{"trials":141,"activeCount":82,"soonestReadout":42},[142],{"nctId":40,"briefTitle":41,"status":143,"phases":144,"primaryCompletion":42,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":149},"ACTIVE_NOT_RECRUITING",[55],"2025-12","2023-02-02",100,[43],[43],{"intervention":151,"totalTrials":82,"cells":152},"Diclofenac Sodium",{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":173},{"trials":154,"activeCount":61},[],{"trials":156,"activeCount":61},[],{"trials":158,"activeCount":61},[],{"trials":160,"activeCount":61},[],{"trials":162,"activeCount":61},[163],{"nctId":164,"briefTitle":165,"status":90,"phases":166,"primaryCompletion":77,"completion":77,"start":167,"enrollment":168,"conditions":169,"interventions":172},"NCT03472339","Clinical Trial Comparing Intravenous and Oral Diclofenac and Pharmacokinetics",[54],"2018-01-15",300,[170,171],"Pain Management","Limb Injury",[151],{"trials":174,"activeCount":61},[],{"intervention":176,"totalTrials":82,"cells":177},"Diclofenac",{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":186,"NA":203},{"trials":179,"activeCount":61},[],{"trials":181,"activeCount":61},[],{"trials":183,"activeCount":61},[],{"trials":185,"activeCount":61},[],{"trials":187,"activeCount":61},[188],{"nctId":189,"briefTitle":190,"status":67,"phases":191,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":199},"NCT02187614","Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management",[54],"2015-02","2015-03","2014-08",1645,[197,198],"Renal Colic","Urinary Calculi",[176,200,201,202],"Morphine","Paracetamol","Placebos",{"trials":204,"activeCount":61},[],{"intervention":200,"totalTrials":82,"cells":206},{"EARLY_PHASE1":207,"PHASE1":209,"PHASE2":211,"PHASE3":213,"PHASE4":215,"NA":221},{"trials":208,"activeCount":61},[],{"trials":210,"activeCount":61},[],{"trials":212,"activeCount":61},[],{"trials":214,"activeCount":61},[],{"trials":216,"activeCount":61},[217],{"nctId":189,"briefTitle":190,"status":67,"phases":218,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":219,"interventions":220},[54],[197,198],[176,200,201,202],{"trials":222,"activeCount":61},[],{"intervention":201,"totalTrials":82,"cells":224},{"EARLY_PHASE1":225,"PHASE1":227,"PHASE2":229,"PHASE3":231,"PHASE4":233,"NA":239},{"trials":226,"activeCount":61},[],{"trials":228,"activeCount":61},[],{"trials":230,"activeCount":61},[],{"trials":232,"activeCount":61},[],{"trials":234,"activeCount":61},[235],{"nctId":189,"briefTitle":190,"status":67,"phases":236,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":237,"interventions":238},[54],[197,198],[176,200,201,202],{"trials":240,"activeCount":61},[],{"intervention":202,"totalTrials":82,"cells":242},{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":257},{"trials":244,"activeCount":61},[],{"trials":246,"activeCount":61},[],{"trials":248,"activeCount":61},[],{"trials":250,"activeCount":61},[],{"trials":252,"activeCount":61},[253],{"nctId":189,"briefTitle":190,"status":67,"phases":254,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":255,"interventions":256},[54],[197,198],[176,200,201,202],{"trials":258,"activeCount":61},[],{"intervention":260,"totalTrials":82,"cells":261},"Levobupivacaine and Fentanyl",{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":270,"NA":284},{"trials":263,"activeCount":61},[],{"trials":265,"activeCount":61},[],{"trials":267,"activeCount":61},[],{"trials":269,"activeCount":61},[],{"trials":271,"activeCount":61},[272],{"nctId":273,"briefTitle":274,"status":67,"phases":275,"primaryCompletion":276,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":283},"NCT06266767","Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia",[54],"2024-10-05","2024-02-21",136,[280,281,282],"Labor Pain","Obstetric Pain","Analgesia",[260],{"trials":285,"activeCount":61},[],{"intervention":287,"totalTrials":82,"cells":288},"Diclofenac and Paracetamol",{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":309},{"trials":290,"activeCount":61},[],{"trials":292,"activeCount":61},[],{"trials":294,"activeCount":61},[],{"trials":296,"activeCount":61},[],{"trials":298,"activeCount":61},[299],{"nctId":300,"briefTitle":301,"status":67,"phases":302,"primaryCompletion":303,"completion":303,"start":304,"enrollment":305,"conditions":306,"interventions":308},"NCT04199572","Synergistic Effect Of Parenteral Diclofenac And Paracetamol In The Pain Management Of Acute Limb Injuries",[54],"2023-02-21","2022-10-16",162,[307],"Musculoskeletal Injury",[287],{"trials":310,"activeCount":61},[],{"intervention":312,"totalTrials":82,"cells":313},"Propranolol",{"EARLY_PHASE1":314,"PHASE1":316,"PHASE2":318,"PHASE3":320,"PHASE4":322,"NA":338},{"trials":315,"activeCount":61},[],{"trials":317,"activeCount":61},[],{"trials":319,"activeCount":61},[],{"trials":321,"activeCount":61},[],{"trials":323,"activeCount":61},[324],{"nctId":325,"briefTitle":326,"status":90,"phases":327,"primaryCompletion":328,"completion":328,"start":329,"enrollment":330,"conditions":331,"interventions":337},"NCT04508244","Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status",[54],"2024-12-31","2020-12-29",771,[332,333,334,335,336],"Trauma","Brain Injuries","Stress Reaction","Beta Blockers","Troponin",[312],{"trials":339,"activeCount":61},[],{"intervention":341,"totalTrials":82,"cells":342},"Enteric Coated Aspirin",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":351,"NA":365},{"trials":344,"activeCount":61},[],{"trials":346,"activeCount":61},[],{"trials":348,"activeCount":61},[],{"trials":350,"activeCount":61},[],{"trials":352,"activeCount":61},[353],{"nctId":354,"briefTitle":355,"status":67,"phases":356,"primaryCompletion":357,"completion":358,"start":359,"enrollment":360,"conditions":361,"interventions":363},"NCT04330872","An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.",[54],"2020-01-04","2020-03-04","2019-08-26",42,[362],"Stroke, Ischemic",[341,364],"Plain Aspirin",{"trials":366,"activeCount":61},[],{"intervention":364,"totalTrials":82,"cells":368},{"EARLY_PHASE1":369,"PHASE1":371,"PHASE2":373,"PHASE3":375,"PHASE4":377,"NA":383},{"trials":370,"activeCount":61},[],{"trials":372,"activeCount":61},[],{"trials":374,"activeCount":61},[],{"trials":376,"activeCount":61},[],{"trials":378,"activeCount":61},[379],{"nctId":354,"briefTitle":355,"status":67,"phases":380,"primaryCompletion":357,"completion":358,"start":359,"enrollment":360,"conditions":381,"interventions":382},[54],[362],[341,364],{"trials":384,"activeCount":61},[],{"intervention":386,"totalTrials":82,"cells":387},"TauroLock U 25000",{"EARLY_PHASE1":388,"PHASE1":390,"PHASE2":392,"PHASE3":394,"PHASE4":396,"NA":409},{"trials":389,"activeCount":61},[],{"trials":391,"activeCount":61},[],{"trials":393,"activeCount":61},[],{"trials":395,"activeCount":61},[],{"trials":397,"activeCount":61},[398],{"nctId":399,"briefTitle":400,"status":67,"phases":401,"primaryCompletion":402,"completion":403,"start":404,"enrollment":405,"conditions":406,"interventions":408},"NCT02868697","Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar",[54],"2015-08","2015-12","2013-11",170,[407],"Hemodialysis, Tunneled Catheter, Qatar",[386],{"trials":410,"activeCount":61},[],{"intervention":412,"totalTrials":82,"cells":413},"Buccal midazolam",{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":422,"NA":435},{"trials":415,"activeCount":61},[],{"trials":417,"activeCount":61},[],{"trials":419,"activeCount":61},[],{"trials":421,"activeCount":61},[],{"trials":423,"activeCount":61},[424],{"nctId":425,"briefTitle":426,"status":67,"phases":427,"primaryCompletion":428,"completion":428,"start":429,"enrollment":430,"conditions":431,"interventions":433},"NCT02897856","Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures",[54],"2018-11","2016-09",150,[432],"Seizures",[412,434],"Intramuscular midazolam",{"trials":436,"activeCount":61},[],{"intervention":434,"totalTrials":82,"cells":438},{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":453},{"trials":440,"activeCount":61},[],{"trials":442,"activeCount":61},[],{"trials":444,"activeCount":61},[],{"trials":446,"activeCount":61},[],{"trials":448,"activeCount":61},[449],{"nctId":425,"briefTitle":426,"status":67,"phases":450,"primaryCompletion":428,"completion":428,"start":429,"enrollment":430,"conditions":451,"interventions":452},[54],[432],[412,434],{"trials":454,"activeCount":61},[],{"intervention":456,"totalTrials":82,"cells":457},"Indocyanine Green",{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":481},{"trials":459,"activeCount":61},[],{"trials":461,"activeCount":61},[],{"trials":463,"activeCount":61},[],{"trials":465,"activeCount":61},[],{"trials":467,"activeCount":61},[468],{"nctId":469,"briefTitle":470,"status":90,"phases":471,"primaryCompletion":472,"completion":473,"start":474,"enrollment":475,"conditions":476,"interventions":480},"NCT04624841","Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis",[54],"2021-12-31","2022-01-15","2021-01-01",80,[477,478,479],"Acute Cholecystitis","Acute; Cholecystitis, Choledocholithiasis","Acute Cholecystitis With Obstruction",[456],{"trials":482,"activeCount":61},[],{"intervention":484,"totalTrials":82,"cells":485},"Bivalirudin",{"EARLY_PHASE1":486,"PHASE1":488,"PHASE2":490,"PHASE3":492,"PHASE4":494,"NA":507},{"trials":487,"activeCount":61},[],{"trials":489,"activeCount":61},[],{"trials":491,"activeCount":61},[],{"trials":493,"activeCount":61},[],{"trials":495,"activeCount":61},[496],{"nctId":497,"briefTitle":498,"status":90,"phases":499,"primaryCompletion":500,"completion":501,"start":502,"enrollment":147,"conditions":503,"interventions":505},"NCT04445935","Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial",[54],"2020-09-28","2021-03-28","2020-06-28",[504],"Anticoagulation in COVID-19 ARDS",[484,506],"Standard treatment",{"trials":508,"activeCount":61},[],{"intervention":506,"totalTrials":82,"cells":510},{"EARLY_PHASE1":511,"PHASE1":513,"PHASE2":515,"PHASE3":517,"PHASE4":519,"NA":525},{"trials":512,"activeCount":61},[],{"trials":514,"activeCount":61},[],{"trials":516,"activeCount":61},[],{"trials":518,"activeCount":61},[],{"trials":520,"activeCount":61},[521],{"nctId":497,"briefTitle":498,"status":90,"phases":522,"primaryCompletion":500,"completion":501,"start":502,"enrollment":147,"conditions":523,"interventions":524},[54],[504],[484,506],{"trials":526,"activeCount":61},[],{"intervention":528,"totalTrials":82,"cells":529},"Epoetin alpha or beta",{"EARLY_PHASE1":530,"PHASE1":532,"PHASE2":534,"PHASE3":536,"PHASE4":538,"NA":553},{"trials":531,"activeCount":61},[],{"trials":533,"activeCount":61},[],{"trials":535,"activeCount":61},[],{"trials":537,"activeCount":61},[],{"trials":539,"activeCount":61},[540],{"nctId":541,"briefTitle":542,"status":67,"phases":543,"primaryCompletion":544,"completion":545,"start":546,"enrollment":547,"conditions":548,"interventions":550},"NCT02049346","Comparison Among Erythropoietin Stimulating Agents",[54],"2013-04","2013-06","2012-03",327,[549],"Anemia of End Stage Renal Disease",[528,551,552],"Darbepoetin alfa","Methoxy polyethylene glycol-epoetin beta",{"trials":554,"activeCount":61},[],{"intervention":551,"totalTrials":82,"cells":556},{"EARLY_PHASE1":557,"PHASE1":559,"PHASE2":561,"PHASE3":563,"PHASE4":565,"NA":571},{"trials":558,"activeCount":61},[],{"trials":560,"activeCount":61},[],{"trials":562,"activeCount":61},[],{"trials":564,"activeCount":61},[],{"trials":566,"activeCount":61},[567],{"nctId":541,"briefTitle":542,"status":67,"phases":568,"primaryCompletion":544,"completion":545,"start":546,"enrollment":547,"conditions":569,"interventions":570},[54],[549],[528,551,552],{"trials":572,"activeCount":61},[],{"intervention":552,"totalTrials":82,"cells":574},{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":581,"PHASE4":583,"NA":589},{"trials":576,"activeCount":61},[],{"trials":578,"activeCount":61},[],{"trials":580,"activeCount":61},[],{"trials":582,"activeCount":61},[],{"trials":584,"activeCount":61},[585],{"nctId":541,"briefTitle":542,"status":67,"phases":586,"primaryCompletion":544,"completion":545,"start":546,"enrollment":547,"conditions":587,"interventions":588},[54],[549],[528,551,552],{"trials":590,"activeCount":61},[],{"intervention":592,"totalTrials":82,"cells":593},"Treatment 1. Metoclopramide",{"EARLY_PHASE1":594,"PHASE1":596,"PHASE2":598,"PHASE3":600,"PHASE4":602,"NA":613},{"trials":595,"activeCount":61},[],{"trials":597,"activeCount":61},[],{"trials":599,"activeCount":61},[],{"trials":601,"activeCount":61},[],{"trials":603,"activeCount":61},[604],{"nctId":605,"briefTitle":606,"status":67,"phases":607,"primaryCompletion":608,"completion":608,"start":609,"enrollment":405,"conditions":610,"interventions":611},"NCT01165866","Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis",[54],"2008-12","2008-06",[28],[592,612],"Treatment 2 Ondansetron",{"trials":614,"activeCount":61},[],{"intervention":612,"totalTrials":82,"cells":616},{"EARLY_PHASE1":617,"PHASE1":619,"PHASE2":621,"PHASE3":623,"PHASE4":625,"NA":631},{"trials":618,"activeCount":61},[],{"trials":620,"activeCount":61},[],{"trials":622,"activeCount":61},[],{"trials":624,"activeCount":61},[],{"trials":626,"activeCount":61},[627],{"nctId":605,"briefTitle":606,"status":67,"phases":628,"primaryCompletion":608,"completion":608,"start":609,"enrollment":405,"conditions":629,"interventions":630},[54],[28],[592,612],{"trials":632,"activeCount":61},[],{"intervention":634,"totalTrials":82,"cells":635},"Fairhaven Pro for men",{"EARLY_PHASE1":636,"PHASE1":638,"PHASE2":640,"PHASE3":642,"PHASE4":644,"NA":658},{"trials":637,"activeCount":61},[],{"trials":639,"activeCount":61},[],{"trials":641,"activeCount":61},[],{"trials":643,"activeCount":61},[],{"trials":645,"activeCount":61},[646],{"nctId":647,"briefTitle":648,"status":90,"phases":649,"primaryCompletion":650,"completion":651,"start":652,"enrollment":147,"conditions":653,"interventions":657},"NCT03464656","Oxidative Stress In Semen And Male Infertility",[54],"2018-07-01","2018-12-01","2018-01-01",[654,655,656],"Antioxidants","Infertility, Male","Semen Quality",[634],{"trials":659,"activeCount":61},[],{"intervention":661,"totalTrials":82,"cells":662},"Treatment 1.",{"EARLY_PHASE1":663,"PHASE1":665,"PHASE2":667,"PHASE3":669,"PHASE4":671,"NA":685},{"trials":664,"activeCount":61},[],{"trials":666,"activeCount":61},[],{"trials":668,"activeCount":61},[],{"trials":670,"activeCount":61},[],{"trials":672,"activeCount":61},[673],{"nctId":674,"briefTitle":675,"status":67,"phases":676,"primaryCompletion":677,"completion":678,"start":679,"enrollment":680,"conditions":681,"interventions":682},"NCT01016249","Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis",[54],"2008-04","2009-04","2007-04",187,[18],[661,683,684],"Treatment 3.","Treatment 2.",{"trials":686,"activeCount":61},[],{"intervention":683,"totalTrials":82,"cells":688},{"EARLY_PHASE1":689,"PHASE1":691,"PHASE2":693,"PHASE3":695,"PHASE4":697,"NA":703},{"trials":690,"activeCount":61},[],{"trials":692,"activeCount":61},[],{"trials":694,"activeCount":61},[],{"trials":696,"activeCount":61},[],{"trials":698,"activeCount":61},[699],{"nctId":674,"briefTitle":675,"status":67,"phases":700,"primaryCompletion":677,"completion":678,"start":679,"enrollment":680,"conditions":701,"interventions":702},[54],[18],[661,683,684],{"trials":704,"activeCount":61},[],{"intervention":684,"totalTrials":82,"cells":706},{"EARLY_PHASE1":707,"PHASE1":709,"PHASE2":711,"PHASE3":713,"PHASE4":715,"NA":721},{"trials":708,"activeCount":61},[],{"trials":710,"activeCount":61},[],{"trials":712,"activeCount":61},[],{"trials":714,"activeCount":61},[],{"trials":716,"activeCount":61},[717],{"nctId":674,"briefTitle":675,"status":67,"phases":718,"primaryCompletion":677,"completion":678,"start":679,"enrollment":680,"conditions":719,"interventions":720},[54],[18],[661,683,684],{"trials":722,"activeCount":61},[],{"intervention":724,"totalTrials":82,"cells":725},"Ceftolozane-tazobactam IV",{"EARLY_PHASE1":726,"PHASE1":728,"PHASE2":730,"PHASE3":732,"PHASE4":734,"NA":748},{"trials":727,"activeCount":61},[],{"trials":729,"activeCount":61},[],{"trials":731,"activeCount":61},[],{"trials":733,"activeCount":61},[],{"trials":735,"activeCount":61},[736],{"nctId":737,"briefTitle":738,"status":739,"phases":740,"primaryCompletion":741,"completion":742,"start":743,"enrollment":61,"conditions":744,"interventions":747},"NCT05061654","CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients","WITHDRAWN",[54],"2024-01","2024-06","2022-08",[745,746],"Neutropenia, Febrile","Hematologic Cancer",[724],{"trials":749,"activeCount":61},[],{"intervention":751,"totalTrials":82,"cells":752},"Evolocumab",{"EARLY_PHASE1":753,"PHASE1":755,"PHASE2":757,"PHASE3":759,"PHASE4":761,"NA":774},{"trials":754,"activeCount":61},[],{"trials":756,"activeCount":61},[],{"trials":758,"activeCount":61},[],{"trials":760,"activeCount":61},[],{"trials":762,"activeCount":61},[763],{"nctId":764,"briefTitle":765,"status":90,"phases":766,"primaryCompletion":767,"completion":767,"start":768,"enrollment":769,"conditions":770,"interventions":773},"NCT05579418","The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients",[54],"2024-10-30","2022-11-01",350,[771,772],"STEMI","Dyslipidemias",[751],{"trials":775,"activeCount":61},[],{"intervention":777,"totalTrials":82,"cells":778},"Tranexamic Acid",{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":785,"PHASE4":797,"NA":799},{"trials":780,"activeCount":61},[],{"trials":782,"activeCount":61},[],{"trials":784,"activeCount":61},[],{"trials":786,"activeCount":61},[787],{"nctId":788,"briefTitle":789,"status":67,"phases":790,"primaryCompletion":791,"completion":792,"start":793,"enrollment":794,"conditions":795,"interventions":796},"NCT03846973","Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid",[53],"2021-01-31","2021-02-10","2018-12-02",220,[777],[777],{"trials":798,"activeCount":61},[],{"trials":800,"activeCount":61},[],{"intervention":802,"totalTrials":82,"cells":803},"Pioglitazone Plus dapaglifliozin",{"EARLY_PHASE1":804,"PHASE1":806,"PHASE2":808,"PHASE3":810,"PHASE4":823,"NA":825},{"trials":805,"activeCount":61},[],{"trials":807,"activeCount":61},[],{"trials":809,"activeCount":61},[],{"trials":811,"activeCount":61},[812],{"nctId":813,"briefTitle":814,"status":90,"phases":815,"primaryCompletion":816,"completion":817,"start":818,"enrollment":819,"conditions":820,"interventions":822},"NCT03794518","Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF",[53],"2021-09","2021-12","2019-03",648,[821],"Risk Reduction",[802],{"trials":824,"activeCount":61},[],{"trials":826,"activeCount":61},[],{"intervention":828,"totalTrials":82,"cells":829},"Nebulized Lidocaine",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":851,"NA":853},{"trials":831,"activeCount":61},[],{"trials":833,"activeCount":61},[],{"trials":835,"activeCount":61},[],{"trials":837,"activeCount":61},[838],{"nctId":839,"briefTitle":840,"status":90,"phases":841,"primaryCompletion":842,"completion":843,"start":844,"enrollment":845,"conditions":846,"interventions":849},"NCT04571879","Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children",[53],"2023-12-30","2024-02-28","2021-08-25",48,[847,848],"Procedural Anxiety","Procedural Pain",[828,850],"Intranasal Midazolam",{"trials":852,"activeCount":61},[],{"trials":854,"activeCount":61},[],{"intervention":850,"totalTrials":82,"cells":856},{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":861,"PHASE3":863,"PHASE4":869,"NA":871},{"trials":858,"activeCount":61},[],{"trials":860,"activeCount":61},[],{"trials":862,"activeCount":61},[],{"trials":864,"activeCount":61},[865],{"nctId":839,"briefTitle":840,"status":90,"phases":866,"primaryCompletion":842,"completion":843,"start":844,"enrollment":845,"conditions":867,"interventions":868},[53],[847,848],[828,850],{"trials":870,"activeCount":61},[],{"trials":872,"activeCount":61},[],{"intervention":874,"totalTrials":82,"cells":875},"Triple therapy group",{"EARLY_PHASE1":876,"PHASE1":878,"PHASE2":880,"PHASE3":882,"PHASE4":897,"NA":899},{"trials":877,"activeCount":61},[],{"trials":879,"activeCount":61},[],{"trials":881,"activeCount":61},[],{"trials":883,"activeCount":61},[884],{"nctId":885,"briefTitle":886,"status":887,"phases":888,"primaryCompletion":889,"completion":890,"start":891,"enrollment":892,"conditions":893,"interventions":896},"NCT03380507","Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock","TERMINATED",[52,53],"2019-10-03","2021-11-01","2018-03-17",106,[894,895],"Septic Shock","Critical Illness",[874],{"trials":898,"activeCount":61},[],{"trials":900,"activeCount":61},[],{"intervention":902,"totalTrials":82,"cells":903},"Anakinra",{"EARLY_PHASE1":904,"PHASE1":906,"PHASE2":908,"PHASE3":910,"PHASE4":925,"NA":927},{"trials":905,"activeCount":61},[],{"trials":907,"activeCount":61},[],{"trials":909,"activeCount":61},[],{"trials":911,"activeCount":61},[912],{"nctId":913,"briefTitle":914,"status":67,"phases":915,"primaryCompletion":916,"completion":917,"start":918,"enrollment":475,"conditions":919,"interventions":924},"NCT04643678","Anakinra in the Management of COVID-19 Infection",[52,53],"2021-03-01","2021-04-30","2020-10-30",[24,920,921,922,923],"Pneumonia","Cytokine Release Syndrome","Corona Virus Infection","Viral Infection",[902],{"trials":926,"activeCount":61},[],{"trials":928,"activeCount":61},[],{"intervention":930,"totalTrials":82,"cells":931},"Dapagliflozin 10mg",{"EARLY_PHASE1":932,"PHASE1":934,"PHASE2":936,"PHASE3":938,"PHASE4":953,"NA":955},{"trials":933,"activeCount":61},[],{"trials":935,"activeCount":61},[],{"trials":937,"activeCount":61},[],{"trials":939,"activeCount":61},[940],{"nctId":941,"briefTitle":942,"status":90,"phases":943,"primaryCompletion":944,"completion":791,"start":945,"enrollment":946,"conditions":947,"interventions":952},"NCT03658031","Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction",[53],"2020-12-31","2019-03-01",576,[948,949,950,951],"PreDiabetes","Myocardial Infarction","T2DM (Type 2 Diabetes Mellitus)","CVD",[930],{"trials":954,"activeCount":61},[],{"trials":956,"activeCount":61},[],{"intervention":958,"totalTrials":82,"cells":959},"Dasatinib 100 MG [Sprycel]",{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":979,"NA":981},{"trials":961,"activeCount":61},[],{"trials":963,"activeCount":61},[],{"trials":965,"activeCount":61},[],{"trials":967,"activeCount":61},[968],{"nctId":969,"briefTitle":970,"status":887,"phases":971,"primaryCompletion":972,"completion":972,"start":973,"enrollment":974,"conditions":975,"interventions":977},"NCT03079505","Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia",[53],"2018-09-23","2017-08-03",10,[976],"Chronic Myeloid Leukemia - Chronic Phase",[958,978],"Nilotinib 150mg oral capsule [Tasigna]",{"trials":980,"activeCount":61},[],{"trials":982,"activeCount":61},[],{"intervention":978,"totalTrials":82,"cells":984},{"EARLY_PHASE1":985,"PHASE1":987,"PHASE2":989,"PHASE3":991,"PHASE4":997,"NA":999},{"trials":986,"activeCount":61},[],{"trials":988,"activeCount":61},[],{"trials":990,"activeCount":61},[],{"trials":992,"activeCount":61},[993],{"nctId":969,"briefTitle":970,"status":887,"phases":994,"primaryCompletion":972,"completion":972,"start":973,"enrollment":974,"conditions":995,"interventions":996},[53],[976],[958,978],{"trials":998,"activeCount":61},[],{"trials":1000,"activeCount":61},[],{"intervention":1002,"totalTrials":82,"cells":1003},"Pred + Meth",{"EARLY_PHASE1":1004,"PHASE1":1006,"PHASE2":1008,"PHASE3":1010,"PHASE4":1023,"NA":1025},{"trials":1005,"activeCount":61},[],{"trials":1007,"activeCount":61},[],{"trials":1009,"activeCount":61},[],{"trials":1011,"activeCount":61},[1012],{"nctId":1013,"briefTitle":1014,"status":90,"phases":1015,"primaryCompletion":1016,"completion":1017,"start":1018,"enrollment":475,"conditions":1019,"interventions":1021},"NCT01724268","Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient",[53],"2014-05","2014-09","2012-05",[1020],"RHEUMATOID ARTHRITIS",[1002,1022],"Anti TNF + Meth",{"trials":1024,"activeCount":61},[],{"trials":1026,"activeCount":61},[],{"intervention":1022,"totalTrials":82,"cells":1028},{"EARLY_PHASE1":1029,"PHASE1":1031,"PHASE2":1033,"PHASE3":1035,"PHASE4":1041,"NA":1043},{"trials":1030,"activeCount":61},[],{"trials":1032,"activeCount":61},[],{"trials":1034,"activeCount":61},[],{"trials":1036,"activeCount":61},[1037],{"nctId":1013,"briefTitle":1014,"status":90,"phases":1038,"primaryCompletion":1016,"completion":1017,"start":1018,"enrollment":475,"conditions":1039,"interventions":1040},[53],[1020],[1002,1022],{"trials":1042,"activeCount":61},[],{"trials":1044,"activeCount":61},[],{"intervention":1046,"totalTrials":82,"cells":1047},"Sildenafil",{"EARLY_PHASE1":1048,"PHASE1":1050,"PHASE2":1052,"PHASE3":1054,"PHASE4":1067,"NA":1069},{"trials":1049,"activeCount":61},[],{"trials":1051,"activeCount":61},[],{"trials":1053,"activeCount":61},[],{"trials":1055,"activeCount":61},[1056],{"nctId":1057,"briefTitle":1058,"status":90,"phases":1059,"primaryCompletion":1060,"completion":1061,"start":1062,"enrollment":147,"conditions":1063,"interventions":1065},"NCT01558466","Sildenofil in Persistent Pulmonary Hypertension in Newborns",[53],"2014-11","2015-06","2011-11",[1064],"Persistent Fetal Circulation Syndrome",[1046,1066],"diluent",{"trials":1068,"activeCount":61},[],{"trials":1070,"activeCount":61},[],{"intervention":1066,"totalTrials":82,"cells":1072},{"EARLY_PHASE1":1073,"PHASE1":1075,"PHASE2":1077,"PHASE3":1079,"PHASE4":1085,"NA":1087},{"trials":1074,"activeCount":61},[],{"trials":1076,"activeCount":61},[],{"trials":1078,"activeCount":61},[],{"trials":1080,"activeCount":61},[1081],{"nctId":1057,"briefTitle":1058,"status":90,"phases":1082,"primaryCompletion":1060,"completion":1061,"start":1062,"enrollment":147,"conditions":1083,"interventions":1084},[53],[1064],[1046,1066],{"trials":1086,"activeCount":61},[],{"trials":1088,"activeCount":61},[],{"intervention":1090,"totalTrials":82,"cells":1091},"Hi-dose iv MgSO4",{"EARLY_PHASE1":1092,"PHASE1":1094,"PHASE2":1096,"PHASE3":1098,"PHASE4":1112,"NA":1114},{"trials":1093,"activeCount":61},[],{"trials":1095,"activeCount":61},[],{"trials":1097,"activeCount":61},[],{"trials":1099,"activeCount":61},[1100],{"nctId":1101,"briefTitle":1102,"status":90,"phases":1103,"primaryCompletion":37,"completion":1104,"start":1061,"enrollment":1105,"conditions":1106,"interventions":1108},"NCT02455687","Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With\u002F Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.",[53],"2025-01",240,[1107],"Bronchial Asthma",[1090,1109,1110,1111],"Nebulized budesonide","Std-dose iv MgSO4","Nebulized normal saline",{"trials":1113,"activeCount":61},[],{"trials":1115,"activeCount":61},[],{"intervention":1109,"totalTrials":82,"cells":1117},{"EARLY_PHASE1":1118,"PHASE1":1120,"PHASE2":1122,"PHASE3":1124,"PHASE4":1130,"NA":1132},{"trials":1119,"activeCount":61},[],{"trials":1121,"activeCount":61},[],{"trials":1123,"activeCount":61},[],{"trials":1125,"activeCount":61},[1126],{"nctId":1101,"briefTitle":1102,"status":90,"phases":1127,"primaryCompletion":37,"completion":1104,"start":1061,"enrollment":1105,"conditions":1128,"interventions":1129},[53],[1107],[1090,1109,1110,1111],{"trials":1131,"activeCount":61},[],{"trials":1133,"activeCount":61},[],{"intervention":1110,"totalTrials":82,"cells":1135},{"EARLY_PHASE1":1136,"PHASE1":1138,"PHASE2":1140,"PHASE3":1142,"PHASE4":1148,"NA":1150},{"trials":1137,"activeCount":61},[],{"trials":1139,"activeCount":61},[],{"trials":1141,"activeCount":61},[],{"trials":1143,"activeCount":61},[1144],{"nctId":1101,"briefTitle":1102,"status":90,"phases":1145,"primaryCompletion":37,"completion":1104,"start":1061,"enrollment":1105,"conditions":1146,"interventions":1147},[53],[1107],[1090,1109,1110,1111],{"trials":1149,"activeCount":61},[],{"trials":1151,"activeCount":61},[],{"intervention":1111,"totalTrials":82,"cells":1153},{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1158,"PHASE3":1160,"PHASE4":1166,"NA":1168},{"trials":1155,"activeCount":61},[],{"trials":1157,"activeCount":61},[],{"trials":1159,"activeCount":61},[],{"trials":1161,"activeCount":61},[1162],{"nctId":1101,"briefTitle":1102,"status":90,"phases":1163,"primaryCompletion":37,"completion":1104,"start":1061,"enrollment":1105,"conditions":1164,"interventions":1165},[53],[1107],[1090,1109,1110,1111],{"trials":1167,"activeCount":61},[],{"trials":1169,"activeCount":61},[],{"intervention":1171,"totalTrials":82,"cells":1172},"Omega 3 fatty acid",{"EARLY_PHASE1":1173,"PHASE1":1175,"PHASE2":1177,"PHASE3":1179,"PHASE4":1191,"NA":1193},{"trials":1174,"activeCount":61},[],{"trials":1176,"activeCount":61},[],{"trials":1178,"activeCount":61},[],{"trials":1180,"activeCount":61},[1181],{"nctId":1182,"briefTitle":1183,"status":90,"phases":1184,"primaryCompletion":1185,"completion":1186,"start":1187,"enrollment":1188,"conditions":1189,"interventions":1190},"NCT04836052","Omega-3 Oil Use in COVID-19 Patients in Qatar",[53],"2021-08-24","2021-12-24","2020-12-24",372,[15],[1171],{"trials":1192,"activeCount":61},[],{"trials":1194,"activeCount":61},[],{"intervention":1196,"totalTrials":82,"cells":1197},"Nebulized Fentanyl",{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1215,"NA":1217},{"trials":1199,"activeCount":61},[],{"trials":1201,"activeCount":61},[],{"trials":1203,"activeCount":61},[],{"trials":1205,"activeCount":61},[1206],{"nctId":1207,"briefTitle":1208,"status":90,"phases":1209,"primaryCompletion":1210,"completion":1211,"start":1212,"enrollment":71,"conditions":1213,"interventions":1214},"NCT05165992","Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19",[53],"2022-11","2022-12","2022-02",[30],[1196],{"trials":1216,"activeCount":61},[],{"trials":1218,"activeCount":61},[],{"intervention":1220,"totalTrials":82,"cells":1221},"Palivizumab",{"EARLY_PHASE1":1222,"PHASE1":1224,"PHASE2":1226,"PHASE3":1228,"PHASE4":1239,"NA":1241},{"trials":1223,"activeCount":61},[],{"trials":1225,"activeCount":61},[],{"trials":1227,"activeCount":61},[],{"trials":1229,"activeCount":61},[1230],{"nctId":1231,"briefTitle":1232,"status":67,"phases":1233,"primaryCompletion":1234,"completion":1234,"start":1017,"enrollment":1235,"conditions":1236,"interventions":1238},"NCT02442427","\"Palivizumab Therapy for RSV-bronchiolitis\"",[53],"2018-02-01",420,[1237],"Respiratory Syncytial Virus-bronchiolitis",[1220],{"trials":1240,"activeCount":61},[],{"trials":1242,"activeCount":61},[],{"intervention":1244,"totalTrials":82,"cells":1245},"Calcitriol",{"EARLY_PHASE1":1246,"PHASE1":1248,"PHASE2":1250,"PHASE3":1252,"PHASE4":1264,"NA":1266},{"trials":1247,"activeCount":61},[],{"trials":1249,"activeCount":61},[],{"trials":1251,"activeCount":61},[],{"trials":1253,"activeCount":61},[1254],{"nctId":1255,"briefTitle":1256,"status":90,"phases":1257,"primaryCompletion":1258,"completion":1258,"start":1259,"enrollment":1260,"conditions":1261,"interventions":1263},"NCT03216564","An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes",[53],"2019-05-10","2017-05-10",320,[1262],"Diabetic Nephropathies",[1244],{"trials":1265,"activeCount":61},[],{"trials":1267,"activeCount":61},[],{"intervention":1269,"totalTrials":82,"cells":1270},"Denosumab 60 MG\u002FML Prefilled Syringe",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1275,"PHASE3":1277,"PHASE4":1290,"NA":1292},{"trials":1272,"activeCount":61},[],{"trials":1274,"activeCount":61},[],{"trials":1276,"activeCount":61},[],{"trials":1278,"activeCount":61},[1279],{"nctId":1280,"briefTitle":1281,"status":887,"phases":1282,"primaryCompletion":1283,"completion":1283,"start":1284,"enrollment":8,"conditions":1285,"interventions":1288},"NCT03040765","Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis",[53],"2019-04-08","2018-05-14",[1286,1287],"Thalassemia Majors (Beta-Thalassemia Major)","Osteoporosis",[1269,1289],"Zoledronic Acid 5Mg\u002FBag 100Ml Inj",{"trials":1291,"activeCount":61},[],{"trials":1293,"activeCount":61},[],{"intervention":1289,"totalTrials":82,"cells":1295},{"EARLY_PHASE1":1296,"PHASE1":1298,"PHASE2":1300,"PHASE3":1302,"PHASE4":1308,"NA":1310},{"trials":1297,"activeCount":61},[],{"trials":1299,"activeCount":61},[],{"trials":1301,"activeCount":61},[],{"trials":1303,"activeCount":61},[1304],{"nctId":1280,"briefTitle":1281,"status":887,"phases":1305,"primaryCompletion":1283,"completion":1283,"start":1284,"enrollment":8,"conditions":1306,"interventions":1307},[53],[1286,1287],[1269,1289],{"trials":1309,"activeCount":61},[],{"trials":1311,"activeCount":61},[],{"intervention":1313,"totalTrials":82,"cells":1314},"Homologous Blood Transfusion",{"EARLY_PHASE1":1315,"PHASE1":1317,"PHASE2":1319,"PHASE3":1321,"PHASE4":1336,"NA":1338},{"trials":1316,"activeCount":61},[],{"trials":1318,"activeCount":61},[],{"trials":1320,"activeCount":61},[],{"trials":1322,"activeCount":61},[1323],{"nctId":1324,"briefTitle":1325,"status":90,"phases":1326,"primaryCompletion":817,"completion":817,"start":1327,"enrollment":1328,"conditions":1329,"interventions":1334},"NCT03548766","Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping",[53],"2018-09-20",12,[1330,1331,1332,1333],"Blood Disease","Blood Transfusion, Autologous","Blood Doping","Blood Transfusion, Homologous",[1313,1335],"Autologous Blood Transfusion",{"trials":1337,"activeCount":61},[],{"trials":1339,"activeCount":61},[],{"intervention":1335,"totalTrials":82,"cells":1341},{"EARLY_PHASE1":1342,"PHASE1":1344,"PHASE2":1346,"PHASE3":1348,"PHASE4":1354,"NA":1356},{"trials":1343,"activeCount":61},[],{"trials":1345,"activeCount":61},[],{"trials":1347,"activeCount":61},[],{"trials":1349,"activeCount":61},[1350],{"nctId":1324,"briefTitle":1325,"status":90,"phases":1351,"primaryCompletion":817,"completion":817,"start":1327,"enrollment":1328,"conditions":1352,"interventions":1353},[53],[1330,1331,1332,1333],[1313,1335],{"trials":1355,"activeCount":61},[],{"trials":1357,"activeCount":61},[],{"intervention":1359,"totalTrials":82,"cells":1360},"Inhaled ILOPROST",{"EARLY_PHASE1":1361,"PHASE1":1363,"PHASE2":1365,"PHASE3":1378,"PHASE4":1380,"NA":1382},{"trials":1362,"activeCount":61},[],{"trials":1364,"activeCount":61},[],{"trials":1366,"activeCount":61},[1367],{"nctId":1368,"briefTitle":1369,"status":67,"phases":1370,"primaryCompletion":1371,"completion":1371,"start":1372,"enrollment":1373,"conditions":1374,"interventions":1377},"NCT04445246","Inhaled Iloprost for Suspected COVID-19 Respiratory Failure",[52],"2021-05-31","2020-05-23",40,[15,1375,1376],"ARDS, Human","Hypoxemic Respiratory Failure",[1359],{"trials":1379,"activeCount":61},[],{"trials":1381,"activeCount":61},[],{"trials":1383,"activeCount":61},[],{"intervention":1385,"totalTrials":82,"cells":1386},"Transdermal estradiol gel",{"EARLY_PHASE1":1387,"PHASE1":1389,"PHASE2":1391,"PHASE3":1403,"PHASE4":1405,"NA":1407},{"trials":1388,"activeCount":61},[],{"trials":1390,"activeCount":61},[],{"trials":1392,"activeCount":61},[1393],{"nctId":1394,"briefTitle":1395,"status":90,"phases":1396,"primaryCompletion":1397,"completion":1398,"start":1399,"enrollment":1400,"conditions":1401,"interventions":1402},"NCT04853069","Oestrogen Treatment for COVID-19 Symptoms",[52],"2022-02-28","2022-03-31","2021-05-17",2000,[15],[1385],{"trials":1404,"activeCount":61},[],{"trials":1406,"activeCount":61},[],{"trials":1408,"activeCount":61},[],{"intervention":1410,"totalTrials":82,"cells":1411},"Taurine",{"EARLY_PHASE1":1412,"PHASE1":1414,"PHASE2":1416,"PHASE3":1432,"PHASE4":1434,"NA":1436},{"trials":1413,"activeCount":61},[],{"trials":1415,"activeCount":61},[],{"trials":1417,"activeCount":61},[1418],{"nctId":1419,"briefTitle":1420,"status":90,"phases":1421,"primaryCompletion":404,"completion":1422,"start":1423,"enrollment":1424,"conditions":1425,"interventions":1431},"NCT01226537","Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients",[51,52],"2014-12","2012-11",20,[1426,1427,1428,1429,1430],"it is a Group of Metabolic Diseases in","Which a Person Has High Blood Sugar, Either","Because the Body Does Not Produce Enough Insulin,","or Because Cells do Not Respond to the Insulin That","is Produced.",[1410],{"trials":1433,"activeCount":61},[],{"trials":1435,"activeCount":61},[],{"trials":1437,"activeCount":61},[],{"intervention":1439,"totalTrials":82,"cells":1440},"Vitamin D",{"EARLY_PHASE1":1441,"PHASE1":1443,"PHASE2":1455,"PHASE3":1457,"PHASE4":1459,"NA":1461},{"trials":1442,"activeCount":61},[],{"trials":1444,"activeCount":61},[1445],{"nctId":1446,"briefTitle":1447,"status":67,"phases":1448,"primaryCompletion":1449,"completion":1450,"start":1451,"enrollment":1452,"conditions":1453,"interventions":1454},"NCT01395589","Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.",[51],"2014-01","2014-06","2011-02",597,[32,43],[1439],{"trials":1456,"activeCount":61},[],{"trials":1458,"activeCount":61},[],{"trials":1460,"activeCount":61},[],{"trials":1462,"activeCount":61},[],{"intervention":1464,"totalTrials":82,"cells":1465},"Ondansetron with1:1 ORA - sweet.",{"EARLY_PHASE1":1466,"PHASE1":1468,"PHASE2":1477,"PHASE3":1479,"PHASE4":1481,"NA":1483},{"trials":1467,"activeCount":61},[],{"trials":1469,"activeCount":61},[1470],{"nctId":1471,"briefTitle":1472,"status":67,"phases":1473,"primaryCompletion":1474,"completion":1474,"start":1017,"enrollment":1373,"conditions":1475,"interventions":1476},"NCT02473887","Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting",[51],"2015-01",[28],[1464],{"trials":1478,"activeCount":61},[],{"trials":1480,"activeCount":61},[],{"trials":1482,"activeCount":61},[],{"trials":1484,"activeCount":61},[],{"intervention":1486,"totalTrials":82,"cells":1487},"Colchicine",{"EARLY_PHASE1":1488,"PHASE1":1500,"PHASE2":1502,"PHASE3":1504,"PHASE4":1506,"NA":1508},{"trials":1489,"activeCount":61},[1490],{"nctId":1491,"briefTitle":1492,"status":90,"phases":1493,"primaryCompletion":1494,"completion":1495,"start":1496,"enrollment":1497,"conditions":1498,"interventions":1499},"NCT05118737","Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.",[50],"2022-04-30","2022-08-30","2021-10-01",230,[30],[1486],{"trials":1501,"activeCount":61},[],{"trials":1503,"activeCount":61},[],{"trials":1505,"activeCount":61},[],{"trials":1507,"activeCount":61},[],{"trials":1509,"activeCount":61},[],{"intervention":1511,"totalTrials":82,"cells":1512},"Intravenous Ibuprofen",{"EARLY_PHASE1":1513,"PHASE1":1525,"PHASE2":1527,"PHASE3":1529,"PHASE4":1531,"NA":1533},{"trials":1514,"activeCount":61},[1515],{"nctId":1516,"briefTitle":1517,"status":67,"phases":1518,"primaryCompletion":1519,"completion":1519,"start":1520,"enrollment":1521,"conditions":1522,"interventions":1524},"NCT04123717","Pilot Study Comparison Of Intravenous Ibuprofen And Intravenous Paracetamol In Management Of Pediatric Fever",[50],"2024-03-07","2019-10-11",147,[1523],"Fever",[1511],{"trials":1526,"activeCount":61},[],{"trials":1528,"activeCount":61},[],{"trials":1530,"activeCount":61},[],{"trials":1532,"activeCount":61},[],{"trials":1534,"activeCount":61},[],{"intervention":1536,"totalTrials":1537,"cells":1538},"Magnesium Sulfate",2,{"EARLY_PHASE1":1539,"PHASE1":1541,"PHASE2":1543,"PHASE3":1554,"PHASE4":1556,"NA":1558},{"trials":1540,"activeCount":61},[],{"trials":1542,"activeCount":61},[],{"trials":1544,"activeCount":61},[1545],{"nctId":1546,"briefTitle":1547,"status":67,"phases":1548,"primaryCompletion":1549,"completion":403,"start":1550,"enrollment":71,"conditions":1551,"interventions":1553},"NCT02145520","Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis",[52],"2015-05","2012-10",[18,1552],"Magnesium, Abnormal Blood Level",[1536],{"trials":1555,"activeCount":61},[],{"trials":1557,"activeCount":61},[],{"trials":1559,"activeCount":61},[1560],{"nctId":1561,"briefTitle":1562,"status":90,"phases":1563,"primaryCompletion":193,"completion":403,"start":1564,"enrollment":1565,"conditions":1566,"interventions":1567},"NCT01584726","Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma",[55],"2012-12",400,[32],[1536],{"intervention":1569,"totalTrials":1537,"cells":1570},"Hydroxychloroquine",{"EARLY_PHASE1":1571,"PHASE1":1573,"PHASE2":1575,"PHASE3":1577,"PHASE4":1589,"NA":1591},{"trials":1572,"activeCount":61},[],{"trials":1574,"activeCount":61},[],{"trials":1576,"activeCount":61},[],{"trials":1578,"activeCount":61},[1579],{"nctId":1580,"briefTitle":1581,"status":90,"phases":1582,"primaryCompletion":1583,"completion":472,"start":1584,"enrollment":1585,"conditions":1586,"interventions":1588},"NCT04437693","Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients",[52,53],"2021-08-30","2020-08-31",500,[1587],"COVID 19",[1569],{"trials":1590,"activeCount":61},[],{"trials":1592,"activeCount":61},[1593],{"nctId":1594,"briefTitle":1595,"status":67,"phases":1596,"primaryCompletion":1597,"completion":1598,"start":1599,"enrollment":1600,"conditions":1601,"interventions":1602},"NCT04349592","Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19",[55],"2020-08-14","2020-08-30","2020-04-14",456,[24],[1569,1603],"Azithromycin",{"intervention":1605,"totalTrials":82,"cells":1606},"Beta-Sitosterol Ointment",{"EARLY_PHASE1":1607,"PHASE1":1609,"PHASE2":1611,"PHASE3":1613,"PHASE4":1615,"NA":1617},{"trials":1608,"activeCount":61},[],{"trials":1610,"activeCount":61},[],{"trials":1612,"activeCount":61},[],{"trials":1614,"activeCount":61},[],{"trials":1616,"activeCount":61},[],{"trials":1618,"activeCount":61},[1619],{"nctId":1620,"briefTitle":1621,"status":67,"phases":1622,"primaryCompletion":1623,"completion":1624,"start":1625,"enrollment":1626,"conditions":1627,"interventions":1630},"NCT07547462","Optimizing Early Cesarean Scar Healing",[55],"2024-10-08","2024-11-01","2023-12-15",117,[1628,1629],"Cesarean Section Scar","Wound Healing",[1605,1631],"Hydrophilic Methacrylate Gel",{"intervention":1631,"totalTrials":82,"cells":1633},{"EARLY_PHASE1":1634,"PHASE1":1636,"PHASE2":1638,"PHASE3":1640,"PHASE4":1642,"NA":1644},{"trials":1635,"activeCount":61},[],{"trials":1637,"activeCount":61},[],{"trials":1639,"activeCount":61},[],{"trials":1641,"activeCount":61},[],{"trials":1643,"activeCount":61},[],{"trials":1645,"activeCount":61},[1646],{"nctId":1620,"briefTitle":1621,"status":67,"phases":1647,"primaryCompletion":1623,"completion":1624,"start":1625,"enrollment":1626,"conditions":1648,"interventions":1649},[55],[1628,1629],[1605,1631],{"intervention":1651,"totalTrials":82,"cells":1652},"Darunavir\u002FCobicistat",{"EARLY_PHASE1":1653,"PHASE1":1655,"PHASE2":1657,"PHASE3":1659,"PHASE4":1661,"NA":1663},{"trials":1654,"activeCount":61},[],{"trials":1656,"activeCount":61},[],{"trials":1658,"activeCount":61},[],{"trials":1660,"activeCount":61},[],{"trials":1662,"activeCount":61},[],{"trials":1664,"activeCount":61},[1665],{"nctId":1666,"briefTitle":1667,"status":67,"phases":1668,"primaryCompletion":1669,"completion":1670,"start":1671,"enrollment":1565,"conditions":1672,"interventions":1675},"NCT04425382","Darunavir\u002FCobicistat vs. Lopinavir\u002FRitonavir in COVID-19 Pneumonia in Qatar",[],"2020-07-31","2020-09-30","2020-03-01",[1673,1674,920],"Coronavirus","COVID",[1651,1676],"Lopinavir\u002FRitonavir",{"intervention":1676,"totalTrials":82,"cells":1678},{"EARLY_PHASE1":1679,"PHASE1":1681,"PHASE2":1683,"PHASE3":1685,"PHASE4":1687,"NA":1689},{"trials":1680,"activeCount":61},[],{"trials":1682,"activeCount":61},[],{"trials":1684,"activeCount":61},[],{"trials":1686,"activeCount":61},[],{"trials":1688,"activeCount":61},[],{"trials":1690,"activeCount":61},[1691],{"nctId":1666,"briefTitle":1667,"status":67,"phases":1692,"primaryCompletion":1669,"completion":1670,"start":1671,"enrollment":1565,"conditions":1693,"interventions":1694},[],[1673,1674,920],[1651,1676],{"intervention":1696,"totalTrials":82,"cells":1697},"Oral paracetamol",{"EARLY_PHASE1":1698,"PHASE1":1700,"PHASE2":1702,"PHASE3":1704,"PHASE4":1706,"NA":1708},{"trials":1699,"activeCount":61},[],{"trials":1701,"activeCount":61},[],{"trials":1703,"activeCount":61},[],{"trials":1705,"activeCount":61},[],{"trials":1707,"activeCount":61},[],{"trials":1709,"activeCount":61},[1710],{"nctId":1711,"briefTitle":1712,"status":67,"phases":1713,"primaryCompletion":1714,"completion":544,"start":1715,"enrollment":1716,"conditions":1717,"interventions":1719},"NCT01891435","The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.",[55],"2011-12","2010-01",434,[1523,1718],"Reduction in Temperature",[1696,1720,1721],"Intravenous paracetamol","Intramuscular diclofenac",{"intervention":1720,"totalTrials":82,"cells":1723},{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1730,"PHASE4":1732,"NA":1734},{"trials":1725,"activeCount":61},[],{"trials":1727,"activeCount":61},[],{"trials":1729,"activeCount":61},[],{"trials":1731,"activeCount":61},[],{"trials":1733,"activeCount":61},[],{"trials":1735,"activeCount":61},[1736],{"nctId":1711,"briefTitle":1712,"status":67,"phases":1737,"primaryCompletion":1714,"completion":544,"start":1715,"enrollment":1716,"conditions":1738,"interventions":1739},[55],[1523,1718],[1696,1720,1721],{"intervention":1721,"totalTrials":82,"cells":1741},{"EARLY_PHASE1":1742,"PHASE1":1744,"PHASE2":1746,"PHASE3":1748,"PHASE4":1750,"NA":1752},{"trials":1743,"activeCount":61},[],{"trials":1745,"activeCount":61},[],{"trials":1747,"activeCount":61},[],{"trials":1749,"activeCount":61},[],{"trials":1751,"activeCount":61},[],{"trials":1753,"activeCount":61},[1754],{"nctId":1711,"briefTitle":1712,"status":67,"phases":1755,"primaryCompletion":1714,"completion":544,"start":1715,"enrollment":1716,"conditions":1756,"interventions":1757},[55],[1523,1718],[1696,1720,1721],{"intervention":1759,"totalTrials":82,"cells":1760},"Caffeine citrate",{"EARLY_PHASE1":1761,"PHASE1":1763,"PHASE2":1765,"PHASE3":1767,"PHASE4":1769,"NA":1771},{"trials":1762,"activeCount":61},[],{"trials":1764,"activeCount":61},[],{"trials":1766,"activeCount":61},[],{"trials":1768,"activeCount":61},[],{"trials":1770,"activeCount":61},[],{"trials":1772,"activeCount":61},[1773],{"nctId":1774,"briefTitle":1775,"status":67,"phases":1776,"primaryCompletion":1016,"completion":1060,"start":1062,"enrollment":1777,"conditions":1778,"interventions":1781},"NCT01435486","Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants",[55],90,[18,1779,1780],"Apnea","Caffeine",[1759,1782],"Normal saline",{"intervention":1782,"totalTrials":82,"cells":1784},{"EARLY_PHASE1":1785,"PHASE1":1787,"PHASE2":1789,"PHASE3":1791,"PHASE4":1793,"NA":1795},{"trials":1786,"activeCount":61},[],{"trials":1788,"activeCount":61},[],{"trials":1790,"activeCount":61},[],{"trials":1792,"activeCount":61},[],{"trials":1794,"activeCount":61},[],{"trials":1796,"activeCount":61},[1797],{"nctId":1774,"briefTitle":1775,"status":67,"phases":1798,"primaryCompletion":1016,"completion":1060,"start":1062,"enrollment":1777,"conditions":1799,"interventions":1800},[55],[18,1779,1780],[1759,1782],{"intervention":1802,"totalTrials":82,"cells":1803},"Levosimendan",{"EARLY_PHASE1":1804,"PHASE1":1806,"PHASE2":1808,"PHASE3":1810,"PHASE4":1812,"NA":1814},{"trials":1805,"activeCount":61},[],{"trials":1807,"activeCount":61},[],{"trials":1809,"activeCount":61},[],{"trials":1811,"activeCount":61},[],{"trials":1813,"activeCount":61},[],{"trials":1815,"activeCount":61},[1816],{"nctId":1817,"briefTitle":1818,"status":90,"phases":1819,"primaryCompletion":1820,"completion":1820,"start":1821,"enrollment":147,"conditions":1822,"interventions":1824},"NCT05730907","Efficacy and Clinical Outcomes of Levosimendan in E-CPR",[],"2023-04-30","2023-02-20",[1823,26],"Cardiogenic Shock",[1802],{"intervention":1826,"totalTrials":82,"cells":1827},"5% human plasma protein fraction",{"EARLY_PHASE1":1828,"PHASE1":1830,"PHASE2":1832,"PHASE3":1834,"PHASE4":1836,"NA":1838},{"trials":1829,"activeCount":61},[],{"trials":1831,"activeCount":61},[],{"trials":1833,"activeCount":61},[],{"trials":1835,"activeCount":61},[],{"trials":1837,"activeCount":61},[],{"trials":1839,"activeCount":61},[1840],{"nctId":1841,"briefTitle":1842,"status":90,"phases":1843,"primaryCompletion":1844,"completion":1844,"start":1845,"enrollment":845,"conditions":1846,"interventions":1849},"NCT05033704","Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries",[55],"2021-09-01","2019-09-09",[1847,1848],"Coagulation; Intravascular","Fluid Electrolyte Disorders",[1826],{"intervention":1851,"totalTrials":82,"cells":1852},"Metformin",{"EARLY_PHASE1":1853,"PHASE1":1855,"PHASE2":1857,"PHASE3":1859,"PHASE4":1861,"NA":1863},{"trials":1854,"activeCount":61},[],{"trials":1856,"activeCount":61},[],{"trials":1858,"activeCount":61},[],{"trials":1860,"activeCount":61},[],{"trials":1862,"activeCount":61},[],{"trials":1864,"activeCount":61},[1865],{"nctId":1866,"briefTitle":1867,"status":90,"phases":1868,"primaryCompletion":1869,"completion":842,"start":1870,"enrollment":1871,"conditions":1872,"interventions":1877},"NCT04855513","Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial",[55],"2023-04-24","2022-03-24",414,[1873,1874,1875,1876],"Preeclampsia","Preeclampsia Severe","High Risk Pregnancy","Eclampsia",[1851],{"intervention":1879,"totalTrials":82,"cells":1880},"Vancomycin-traditional dosing",{"EARLY_PHASE1":1881,"PHASE1":1883,"PHASE2":1885,"PHASE3":1887,"PHASE4":1889,"NA":1891},{"trials":1882,"activeCount":61},[],{"trials":1884,"activeCount":61},[],{"trials":1886,"activeCount":61},[],{"trials":1888,"activeCount":61},[],{"trials":1890,"activeCount":61},[],{"trials":1892,"activeCount":61},[1893],{"nctId":1894,"briefTitle":1895,"status":67,"phases":1896,"primaryCompletion":1897,"completion":1898,"start":1899,"enrollment":1900,"conditions":1901,"interventions":1903},"NCT04297176","Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods",[55],"2021-05-04","2021-07-02","2020-01-23",65,[1902],"Infection, Bacterial",[1879,1904],"Vancomycin- Trough-only based dosing",{"intervention":1904,"totalTrials":82,"cells":1906},{"EARLY_PHASE1":1907,"PHASE1":1909,"PHASE2":1911,"PHASE3":1913,"PHASE4":1915,"NA":1917},{"trials":1908,"activeCount":61},[],{"trials":1910,"activeCount":61},[],{"trials":1912,"activeCount":61},[],{"trials":1914,"activeCount":61},[],{"trials":1916,"activeCount":61},[],{"trials":1918,"activeCount":61},[1919],{"nctId":1894,"briefTitle":1895,"status":67,"phases":1920,"primaryCompletion":1897,"completion":1898,"start":1899,"enrollment":1900,"conditions":1921,"interventions":1922},[55],[1902],[1879,1904],{"intervention":1603,"totalTrials":82,"cells":1924},{"EARLY_PHASE1":1925,"PHASE1":1927,"PHASE2":1929,"PHASE3":1931,"PHASE4":1933,"NA":1935},{"trials":1926,"activeCount":61},[],{"trials":1928,"activeCount":61},[],{"trials":1930,"activeCount":61},[],{"trials":1932,"activeCount":61},[],{"trials":1934,"activeCount":61},[],{"trials":1936,"activeCount":61},[1937],{"nctId":1594,"briefTitle":1595,"status":67,"phases":1938,"primaryCompletion":1597,"completion":1598,"start":1599,"enrollment":1600,"conditions":1939,"interventions":1940},[55],[24],[1569,1603],{"intervention":1942,"totalTrials":82,"cells":1943},"SGLT2 inhibitor",{"EARLY_PHASE1":1944,"PHASE1":1946,"PHASE2":1948,"PHASE3":1950,"PHASE4":1952,"NA":1954},{"trials":1945,"activeCount":61},[],{"trials":1947,"activeCount":61},[],{"trials":1949,"activeCount":61},[],{"trials":1951,"activeCount":61},[],{"trials":1953,"activeCount":61},[],{"trials":1955,"activeCount":61},[1956],{"nctId":1957,"briefTitle":1958,"status":90,"phases":1959,"primaryCompletion":1960,"completion":1961,"start":1962,"enrollment":1963,"conditions":1964,"interventions":1966},"NCT06251453","Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery",[],"2024-12-01","2025-01-31","2023-10-01",3280,[1965],"Atrial Fibrillation",[1942]]